https://www.prnewswire.com/news-releases/chmp-recommends-approval-of-lillys-olaratumab-in-combination-with-doxorubicin-for-advanced-soft-tissue-sarcoma-300329369.html
CHMP Recommends Approval of Lilly's Olaratumab, in Combination with Doxorubicin, for Advanced Soft...
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use...
https://pubmed.ncbi.nlm.nih.gov/?term=olaratumab%5BTitle%2FAbstract%5D&cmd=DetailsSearch
olaratumab[Title/Abstract] - Search Results - PubMed
olaratumab[Title/Abstract] - Search Results - PubMed
abstract searcholaratumabtitleresultspubmed